RECRUITING

Natural History of Sickle Cell Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center.

Official Title

Studies of the Natural History of Sickle Cell Disease

Quick Facts

Study Start:2004-04-29
Study Completion:N/A
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00081523

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals with known or suspected sickle cell disease
  2. * 2 years of age and older
  3. * Willing to provide informed consent or appropriate informed consent from parent or legal guardian
  4. * Patients seen at sickle outpatient clinics at any one of the participating centers (CNHS or NIH).
  1. * Patient and/or guardian unable and unwilling to give informed consent or assent.
  2. * Patients less than 2 years of age.

Contacts and Locations

Study Contact

Nancy A Asomaning
CONTACT
(301) 605-0398
nancy.asomaning@nih.gov

Principal Investigator

Swee Lay Thein, M.D.
PRINCIPAL_INVESTIGATOR
National Heart, Lung, and Blood Institute (NHLBI)

Study Locations (Sites)

Childrens National Health Center
Washington D.C., District of Columbia, 20010
United States
Suburban Hospital
Bethesda, Maryland, 20814
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
United States

Collaborators and Investigators

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

  • Swee Lay Thein, M.D., PRINCIPAL_INVESTIGATOR, National Heart, Lung, and Blood Institute (NHLBI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2004-04-29
Study Completion DateN/A

Study Record Updates

Study Start Date2004-04-29
Study Completion DateN/A

Terms related to this study

Keywords Provided by Researchers

  • Hemoglobin
  • Acute Chest Syndrome
  • Treatment Options
  • Nitric Oxide
  • Pulmonary Hypertension
  • Natural History

Additional Relevant MeSH Terms

  • Pain Crisis